The Effect of Influenza Vaccination for the Elderly on Hospitalization and Mortality: An Observational Study With a Regression Discontinuity Design.


Journal

Annals of internal medicine
ISSN: 1539-3704
Titre abrégé: Ann Intern Med
Pays: United States
ID NLM: 0372351

Informations de publication

Date de publication:
07 04 2020
Historique:
pubmed: 3 3 2020
medline: 8 9 2020
entrez: 3 3 2020
Statut: ppublish

Résumé

Observational studies using traditional research designs suggest that influenza vaccination reduces hospitalizations and mortality among elderly persons. Accordingly, health authorities in some countries prioritize vaccination of this population. Nevertheless, questions remain about this policy's effectiveness given the potential for bias and confounding in observational data. To determine the effectiveness of the influenza vaccine in reducing hospitalizations and mortality among elderly persons by using an observational research design that reduces the possibility of bias and confounding. A regression discontinuity design was applied to the sharp change in vaccination rate at age 65 years that resulted from an age-based vaccination policy in the United Kingdom. In this design, comparisons were limited to individuals who were near the age-65 threshold and were thus plausibly similar along most dimensions except vaccination rate. England and Wales. Adults aged 55 to 75 years residing in the study area during 2000 to 2014. Seasonal influenza vaccine. Hospitalization and mortality rates by month of age. The data included 170 million episodes of care and 7.6 million deaths. Turning 65 was associated with a statistically and clinically significant increase in rate of seasonal influenza vaccination. However, no evidence indicated that vaccination reduced hospitalizations or mortality among elderly persons. The estimates were precise enough to rule out results from many previous studies. The study relied on observational data, and its focus was limited to individuals near age 65 years. Current vaccination strategies prioritizing elderly persons may be less effective than believed at reducing serious morbidity and mortality in this population, which suggests that supplementary strategies may be necessary. National Institute on Aging.

Sections du résumé

Background
Observational studies using traditional research designs suggest that influenza vaccination reduces hospitalizations and mortality among elderly persons. Accordingly, health authorities in some countries prioritize vaccination of this population. Nevertheless, questions remain about this policy's effectiveness given the potential for bias and confounding in observational data.
Objective
To determine the effectiveness of the influenza vaccine in reducing hospitalizations and mortality among elderly persons by using an observational research design that reduces the possibility of bias and confounding.
Design
A regression discontinuity design was applied to the sharp change in vaccination rate at age 65 years that resulted from an age-based vaccination policy in the United Kingdom. In this design, comparisons were limited to individuals who were near the age-65 threshold and were thus plausibly similar along most dimensions except vaccination rate.
Setting
England and Wales.
Participants
Adults aged 55 to 75 years residing in the study area during 2000 to 2014.
Intervention
Seasonal influenza vaccine.
Measurements
Hospitalization and mortality rates by month of age.
Results
The data included 170 million episodes of care and 7.6 million deaths. Turning 65 was associated with a statistically and clinically significant increase in rate of seasonal influenza vaccination. However, no evidence indicated that vaccination reduced hospitalizations or mortality among elderly persons. The estimates were precise enough to rule out results from many previous studies.
Limitation
The study relied on observational data, and its focus was limited to individuals near age 65 years.
Conclusion
Current vaccination strategies prioritizing elderly persons may be less effective than believed at reducing serious morbidity and mortality in this population, which suggests that supplementary strategies may be necessary.
Primary Funding Source
National Institute on Aging.

Identifiants

pubmed: 32120383
pii: 2762506
doi: 10.7326/M19-3075
doi:

Substances chimiques

Influenza Vaccines 0

Types de publication

Journal Article Observational Study Research Support, N.I.H., Extramural Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

445-452

Subventions

Organisme : NIA NIH HHS
ID : R01 AG044796
Pays : United States

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Auteurs

Michael L Anderson (ML)

University of California, Berkeley, Berkeley, California, and National Bureau of Economic Research, Cambridge, Massachusetts (M.L.A.).

Carlos Dobkin (C)

University of California, Santa Cruz, Santa Cruz, California, and National Bureau of Economic Research, Cambridge, Massachusetts (C.D.).

Devon Gorry (D)

Clemson University, Clemson, South Carolina (D.G.).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH